Keywords
issues
strategies
COVID-19
HIV/AIDS
tuberculosis
Categories
How to Cite
Abstract
Summary: Globalization and the interconnectedness of countries in the modern world pose new challenges to public health. Over the centuries, infectious diseases have proven to be one of the major threats to global health. Historically, several pandemics and epidemics have changed and claimed the lives of millions of people around the world. Many infectious agents continue to pose a serious problem despite advances in medicine, public health awareness campaigns and vaccination. The aim of this review is to review global epidemiological trends and challenges related to three key infectious diseases: COVID-19, HIV/AIDS, and tuberculosis. The COVID-19 pandemic, along with the long-standing threats of HIV/AIDS and tuberculosis, is posing a serious challenge to health systems and socio-economic structures in many countries. COVID-19, caused by SARS-CoV-2, has spread rapidly around the world, resulting in significant numbers of cases, deaths, and long-term health problems. The consequences of infection “long” COVID-19 and post-COVID-19 unlocked syndromes have become one of the main causes of reduced work capacity and impaired quality of life in recent years. At the same time, HIV/AIDS remains a global health problem, especially in certain regions, and tuberculosis continues to pose a serious threat, especially in conditions of limited access to health services. Each of these health problems poses specific requirements for treatment and prevention, while leading to serious health, social and economic consequences, despite global initiatives and strategies to address them.
References
Burkert FR, Lanser L, Bellmann-Weiler R, Weiss G. Coronavirus Disease 2019: Clinics, Treatment, and Prevention. Front. Microbiol., 11 November 2021, Sec. Infectious Agents and Disease, Volume 12-2021 | [https://doi.org/10.3389/fmicb.2021.761887](https://www.google.com/search?q=https://doi.org/10.3389/fmicb.2021.761887)
Ramos-Casals M, Brito-Zerón P, Mariette X. Systemic and organ-specific immune-related manifestations of COVID-19. Nature REVIEWS. Rheumatology. 2021 Jun;17(6):315-332. doi: 10.1038/s41584-021-00608-z. Epub 2021 Apr 26.
Емин С, Бояджиева Вл, Стоилов Н и др. Автоимунни заболявания, отключени след ваксинация срещу COVID-19. MedInfo 2022;5:18-21.
Dimova Z, Boyadzhieva V, Stoilov N, et al. COVID-19 in autoimmune rheumatic diseases – frequency, course, effectiveness and complications in vaccination. Rheumatology (Bulgaria), 2021;29(4), 87-98. [https://doi.org/10.35465/29.4.2021.pp87-98](https://www.google.com/search?q=https://doi.org/10.35465/29.4.2021.pp87-98)
Stoilov N, Boyadzhieva V. SARS-CoV-2 and autoimmune rheumatic diseases. Rheumatology (Bulgaria), 2021;28(4), 36-44. [https://doi.org/10.35465/28.4.2020.pp36-44](https://doi.org/10.35465/28.4.2020.pp36-44)
Dimova Z, Boyadzhieva V, Stoilov N, et al. A clinical case of a patient with mucocutaneous and musculoskeletal manifestations after COVID-19 vaccination. Rheumatology (Bulgaria), 2022;30;(2),102-107. [https://doi.org/10.35465/30.2.2022.pp102-107](https://www.google.com/search?q=https://doi.org/10.35465/30.2.2022.pp102-107)
Vanaparthy R, Malayala SV, Balla M. COVID-19-Induced Vestibular Neuritis, Hemi-Facial Spasms and Raynaud‘s Phenomenon: A Case Report. Cureus. 2020 Nov; 12(11): e11752. doi: 10.7759/cureus.11752
Sulli A, Gotelli E, Bica PF. Detailed videocapillaroscopic microvascular changes detectable in adult COVID-19 survivors.
Çakmak F, Demirbuga A, Demirkol D, et al. Nailfold capillaroscopy: A sensitive method for evaluating microvascular involvement in children with SARS-CoV-2 infection. Microvascular Research. Volume 138, November 2021, 104196. doi: 10.1016/j.mvr.2021.104196
Natalello G, De Luca G, Gigante L, et al. Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. Microvascular Research 2021 Jan;133:104071. doi: 10.1016/j.mvr.2020.104071.
Doncheva-Dilova J, Boyadzhieva V, Stoilov, N. Clinical and immune-related manifestations in patients with COVID-19. Rheumatology (Bulgaria), 2023;31(1),54-94. [https://doi.org/10.35465/31.1.2023.pp54-94](https://doi.org/10.35465/31.1.2023.pp54-94)
Joshee S, Vatti N, Chang C. Long-Term Effects of COVID-19. Mayo Clin Proc 2022;97:57999. [https://doi.org/10.1016/j.mayocp.2021.12.017](https://www.google.com/search?q=https://doi.org/10.1016/j.mayocp.2021.12.017)
WHO. COVID-19 epidemiological update – 24 December 2024. Available at: [https://cdn.who.int/media/docs/default-source/documents/emergencies/20241224_covid-19_epi_update_special-edition.pdf?sfvrsn=b0a6dd-af_1&download=true](https://www.google.com/search?q=https://cdn.who.int/media/docs/default-source/documents/emergencies/20241224_covid-19_epi_update_special-edition.pdf%3Fsfvrsn%3Db0a6dd-af_1%26download%3Dtrue)
Limb M. Covid-19: Recognise long covid as occupational disease and compensate frontline workers, say MPs BMJ 2021; 372:n503 doi:10.1136/bmj.n503 [https://www.bmj.com/content/372/bmj.n503](https://www.bmj.com/content/372/bmj.n503)
Himmelstein DU, Woolhandler S. Health insurance status and risk factors for poor outcomes with COVID-19 among U.S. health care workers: a cross-sectional study. Ann Intern Med. 2020; 173: 410-412. [https://doi.org/10.7326/m20-1874](https://doi.org/10.7326/m20-1874)
McMahon DE, Peters GA, Ivers LC, Freeman EE. Global resource shortages during COVID-19: Bad news for low-income countries. PLoS Negl Trop Dis. 2020; 14(7):e0008412. [https://doi.org/10.1371/journal.pntd.0008412](https://doi.org/10.1371/journal.pntd.0008412)
Covid-19: An Occupational Disease, TUC, August 2022
Workers’ experiences of long Covid, A joint report by the TUC and Long Covid Support, March 2023. [https://www.tuc.org.uk/sites/default/files/2023-03/Long%20Covid%20at%20Work%20report%20-%20FINAL%20COLOUR%202.pdf](https://www.tuc.org.uk/sites/default/files/2023-03/Long%20Covid%20at%20Work%20report%20-%20FINAL%20COLOUR%202.pdf)
Robinson-Lane SG, Sutton NR, Chubb H, et al. Ethnicity, and 60-Day Outcomes After Hospitalization With COVID-19. J Am Med Dir Assoc. 2021;22(11):2245-2250. doi: 10.1016/j.jamda.2021.08.023.
Chopra V, Flanders SA, O’Malley M, et al. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Ann Intern Med. 2021 Apr;174(4):576-578. doi: 10.7326/M20-5661. Epub 2020 Nov 11. PMID: 33175566; PMCID: PMC7707210.
Richards F, Kodjamanova P, Chen X, et al. Economic Burden of COVID-19: A Systematic Review. Clinicoecon Outcomes Res. 2022 Apr 28;14:293-307. doi: 10.2147/CEOR.S338225.
Doncheva-Dilova J, Boyadzhieva V, Kuneva T. COVID-19 and post-COVID-19 syndrome as an occupational disease. Rheumatology (Bulgaria), 2024;31(4),60-77. [https://doi.org/10.35465/31.4.2023.pp60-77](https://www.google.com/search?q=https://doi.org/10.35465/31.4.2023.pp60-77)
Filip R, Gheorghita Puscaselu R, Anchidin-Norocel L et al. Global Challenges to Public Health Care Systems during the COVID-19 Pandemic: A Review of Pandemic Measures and Problems. J Pers Med. 2022 Aug 7;12(8):1295. doi: 10.3390/jpm12081295.
Naeem FN, Hasan SFS, Ram MD, et al. The association between SARS-CoV-2 vaccines and transverse myelitis: A review. Ann Med Surg (Lond). 2022 Jun 9;79:103870. doi: 10.1016/j.amsu.2022.103870.
Cherif YYS, Djeffal C, Abu Serhan H, et al. The Characteristics of COVID-19 Vaccine-Associated Uveitis: A Summative Systematic Review. Vaccines 2023, 11, 69. [https://doi.org/10.3390/vaccines11010069](https://www.google.com/search?q=https://doi.org/10.3390/vaccines11010069)
Carlsten C, Gulati M, Hines S, et al. COVID-19 as an occupational disease. Am J Ind Med. 2021 Apr;64(4):227-237. doi: 10.1002/ajim.23222.
Burdorf A, Porru F, Rugulies R. The COVID-19 (Coronavirus) pandemic: consequences for occupational health. Scand J Work Environ Health. 2020;1;46(3):229-230. doi: 10.5271/sjweh.3893.
WHO. COVAX. Working for global equitable access to COVID-19 vaccines. Available from: [https://www.who.int/initiatives/act-accelerator/covax](https://www.who.int/initiatives/act-accelerator/covax)
Димитров И, Владимиров К. Мерки за рестарт на туризма и успешното провеждане на сезон 2021 в условията на COVID-19 – Сборник доклади от Черноморски туристически форум, 131-142, ISBN 978-954-9741-45-2 – 2021.
European Commission. (2020, July 21). EU leaders agree on €1.8 trillion budget and recovery plan. European Commission. Available at: [https://ec.europa.eu/commission/press-corner/detail/en/ip_20_2073](https://www.google.com/search?q=https://ec.europa.eu/commission/press-corner/detail/en/ip_20_2073)
The White House. (2021, March 11). The American Rescue Plan Act of 2021: A comprehensive economic relief package. The White House. Available at: [https://www.whitehouse.gov/american-rescue-plan](https://www.google.com/search?q=https://www.whitehouse.gov/american-rescue-plan)
Federal Transit Administration. American Rescue Plan Act of 2021. Available from: [https://www.transit.dot.gov/funding/american-rescue-plan-act-2021](https://www.transit.dot.gov/funding/american-rescue-plan-act-2021)
U.S. Department of Labor. Delivering immediate relief to America‘s workers. Available from: [https://www.dol.gov/general/american-rescue-plan](https://www.google.com/search?q=https://www.dol.gov/general/american-rescue-plan)
World Health Organization (WHO). (2021). COVID-19 vaccination and social distancing: Global challenges and successes. World Health Organization. [https://www.who.int/news-room/fact-sheets/detail/coronavirus-disease-(covid-19](https://www.who.int/news-room/fact-sheets/detail/coronavirus-disease-(covid-19))
Gössling S, Scott D, Hall, C. M. Pandemics, tourism and global change: A rapid assessment of COVID-19. Journal of Sustainable Tourism, 2020;29(1),1-19.
Fuchs F, Morf H, Mohn J et al. Diagnostic delay stages and pre-diagnostic treatment in patients with suspected rheumatic diseases before special care consultation: results of a multicenter-based study. Rheumatol Int 2023, 43, 495-502. [https://doi.org/10.1007/s00296-022-05223](https://doi.org/10.1007/s00296-022-05223).
Dimitrov I. Medical and SPA tourism and rheumatic diseases – challenges and future perspective. Rheumatology (Bulgaria), 2024;32(1), 30-44. [https://doi.org/10.35465/32.1.2024.pp30-44](https://doi.org/10.35465/32.1.2024.pp30-44)
Widdifield J, Bernatsky S, Thorne JC, et al. Wait times to rheumatology care for patients with rheumatic diseases: a data linkage study of primary care electronic medical records and administrative data. CMAJ Open. 2016;11;4(2):E205-12. doi: 10.9778/cmajo.20150116.
United Nations Programme on HIV/AIDS (UNAIDS). Global HIV & AIDS Statistics. UNAIDS. Available at: [https://www.unaids.org](https://www.unaids.org)
World Health Organization (WHO). Global Health Reports. World Health Organization. Available at: [https://www.who.int](https://www.who.int)
Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030. Available at: [https://iris.who.int/bitstream/handle/10665/360348/9789240053779-eng.pdf?sequence=1](https://iris.who.int/bitstream/handle/10665/360348/9789240053779-eng.pdf?sequence=1)
Checkpoint. Център за сексуално здраве София. PrEP. Налично на: [https://checkpointsofia.info/useful/prep/](https://checkpointsofia.info/useful/prep/)
U.S. Department of State. The Global Fund to Fight AIDS, Tuberculosis, and Malaria. U.S. Government Positions on Decision Points from the Forty-sixth Board Meeting of the Global Fund. Available at: [https://www.state.gov/wp-content/uploads/2021/12/Outcomes-of-the-GF-46th-Board-Meeting-Final.pdf](https://www.state.gov/wp-content/uploads/2021/12/Outcomes-of-the-GF-46th-Board-Meeting-Final.pdf)
Община Варна. „Дирекция Превенции“. Лечение при ХИВ и СПИН. Налично на: [https://prevencii.com/index.php/pol-inf/%D1%85%D0%B8%D0%B2-%D1%81%D0%BF%D0%B8%D0%BD/30-%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5-%D0%BF%D1%80%D0%B8-%D1%85%D0%B8%D0%B2-%D0%B8-%D1%81%D0%BF%D0%B8%D0%BD](https://www.google.com/search?q=https://prevencii.com/index.php/pol-inf/%25D1%2585%25D0%25B8%25D0%25B2-%25D1%2581%25D0%25BF%25D0%25B8%25D0%25BD/30-%25D0%25BB%25D0%25B5%25D1%2587%25D0%25B5%25D0%25BD%25D0%25B8%25D0%25B5-%25D0%25BF%25D1%2580%25D0%25B8-%25D1%2585%25D0%25B8%25D0%25B2-%25D0%25B8-%25D1%2581%25D0%25BF%25D0%25B8%25D0%25BD)
Clinica.bg. Днес е достатъчна 1 таблетка срещу ХИВ. Налично на: [https://clinica.bg/22822-dnes-e-dostatychna-1-tabletka-sreshtu-hiv](https://clinica.bg/22822-dnes-e-dostatychna-1-tabletka-sreshtu-hiv)
World Health Organization (WHO). Global Tuberculosis Report 2024. World Health Organization. Available at: [https://iris.who.int/bitstream/handle/10665/379339/9789240101531-eng.pdf?sequence=1](https://iris.who.int/bitstream/handle/10665/379339/9789240101531-eng.pdf?sequence=1)
Дончева-Дилова Ж, Миланов В. Силикотуберкулоза – съвременни аспекти, предизвикателства и подходи. Обща медицина, 2023, 25(6), 44-52
Sharma N, Kundu D, Dhaked S et al. Silicosis and silicotuberculosis in India. Bull World Health Organ, 2016;94(10):777-778. doi: 10.2471/BLT.15.163550.
Dheda K, Barry CE 3rd, Maartens G. Tuberculosis. Lancet, 2016;387(10024):1211-26. doi: 10.1016/S0140-6736(15)00151-8
Corbett EL, Churchyard GJ, Clayton T et al. Risk factors for pulmonary mycobacterial disease in South African gold miners. A case-control study. Am J Respir Crit Care Med, 1999;159(1):94-9. doi: 10.1164/ajrccm.159.1.9803048.
Stop TB Partnership. Available at: [https://www.stoptb.org](https://www.stoptb.org)
International Labour Organization. Biological hazards in the working environment. Geneva: International Labour Office, 2022. ISBN 978-92-2-038343-8 (web PDF). Налично на: [https://www.ilo.org/resource/conference-paper/biological-hazards-working-environment](https://www.ilo.org/resource/conference-paper/biological-hazards-working-environment).
Corrao CR, Mazzotta A, La Torre G, et al. Biological risk and occupational health. Ind Health. 2012;50(4):326-37. doi: 10.2486/indhealth.ms1324. Epub 2012 Jun 13.
Eurofound (2017), Sixth European Working Conditions Survey – Overview report (2017 update), Publications Office of the European Union, Luxembourg. European Foundation for the Improvement of Living and Working Conditions, 2017. doi: 10.2806/422172; TJ-02-17-731-EN-N. Налично на: [https://www.eurofound.europa.eu/en/publications/2016/sixth-european-working-conditions-survey-overview-report](https://www.eurofound.europa.eu/en/publications/2016/sixth-european-working-conditions-survey-overview-report).
Takala J, Descatha A, Oppliger A, et al. Global Estimates on Biological Risks at Work. Saf Health Work. 2023 Dec;14(4):390-397. doi: 10.1016/j.shaw.2023.10.005.
UNI Global Union и ITUC. COVID-19: an occupational disease where frontline workers are best protected. 18.05.21 [https://uniglobalunion.org/report/covid-19-an-occupational-disease-where-frontline-workers-are-best-protected/?fbclid=IwAR2yuptL4sNJNgy6pAezs1h30xFoOU8cR5lfK-wqPZSJcw7fpSQwhsVgtuRQ57](https://www.google.com/search?q=https://uniglobalunion.org/report/covid-19-an-occupational-disease-where-frontline-workers-are-best-protected/%3Ffbclid%3DIwAR2yuptL4sNJNgy6pAezs1h30xFoOU8cR5lfK-wqPZSJcw7fpSQwhsVgtuRQ57). Sandal A, Yildiz AN. COVID-19 as a Recognized Work-Related Disease: The Current Situation Worldwide. Saf Health Work. 2021 Mar;12(1):136-138. doi: 10.1016/j.shaw.2021.01.001.
Национална здравна стратегия 2020. Налична на: [https://old.parliament.bg/pub/plenary_documents/502-03-20_Natsionalna%20zdravna%20strategiya%202020.pdf](https://www.google.com/search?q=https://old.parliament.bg/pub/plenary_documents/502-03-20_Natsionalna%2520zdravna%2520strategiya%25202020.pdf).
Национален център по обществено здраве и анализи. Годишен доклад за състоянието на здравето на гражданите в Република България за 2022 г. София, 2022. Налично на: [https://ncpha.government.bg/index/103-dokladi-i-analizi.html](https://ncpha.government.bg/index/103-dokladi-i-analizi.html).
Министерство на здравеопазването на Република България. Налично на: [https://www.mh.government.bg/](https://www.mh.government.bg/)
Национален център по заразни и паразитни болести. Налично на: [https://www.ncipd.org/index.php?lang=bg](https://www.ncipd.org/index.php?lang=bg)
United Nations. Sustainable Development Goals. Available at: [https://sdgs.un.org/goals](https://sdgs.un.org/goals)
Национална програма за превенция и контрол на хив и сексуално предавани инфекции в Република България 2021-2025 г.
Министерски съвет. Национална програма за превенция и контрол на ХИВ и сексуално предавани инфекции в Република България за периода 2021-2025 г. Налично на: [https://www.mh.government.bg/media/filer_public/2021/08/13/21rh594pr1.pdf](https://www.google.com/search?q=https://www.mh.government.bg/media/filer_public/2021/08/13/21rh594pr1.pdf)
Министерство на здравеопазването. Национален център по обществено здраве и анализи. Здравеопазване. Кратък статистически справочник. Налично на: [https://ncpha.government.bg](https://ncpha.government.bg)./uploads/magazines/healthcare/Healthcare_24.pdf
Национален осигурителен институт. Статистическа система „Професионални болести». Признати професионални болести. 2009-2022 г. Налично на: [https://www.nssi.bg/publikacii/statistika/trudovi-zlopoluki/informatsiya-za-profesionalni-bolesti/](https://www.google.com/search?q=https://www.nssi.bg/publikacii/statistika/trudovi-zlopoluki/informatsiya-za-profesionalni-bolesti/).
Вангелова К. Превенция на професионалните и свързани с труда заболявания. Списание „Здраве и безопасност при работа“. Национален център по обществено здраве и анализи. 2022, 8.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Jaklin Svetoslavova Doncheva - Dilova, V Milanov, Vladimira Boyadzhieva, Nikolay Stoilov (Author)